BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 30134787)

  • 1. Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction.
    Fillmore N; Levasseur JL; Fukushima A; Wagg CS; Wang W; Dyck JRB; Lopaschuk GD
    Mol Med; 2018 Mar; 24(1):3. PubMed ID: 30134787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
    Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
    Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial fatty acid oxidation is the major source of cardiac adenosine triphosphate production in heart failure with preserved ejection fraction.
    Sun Q; Güven B; Wagg CS; Almeida de Oliveira A; Silver H; Zhang L; Chen B; Wei K; Ketema EB; Karwi QG; Persad KL; Vu J; Wang F; Dyck JRB; Oudit GY; Lopaschuk GD
    Cardiovasc Res; 2024 Mar; 120(4):360-371. PubMed ID: 38193548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction.
    Mori J; Basu R; McLean BA; Das SK; Zhang L; Patel VB; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
    Circ Heart Fail; 2012 Jul; 5(4):493-503. PubMed ID: 22705769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased rates of substrate oxidation ex vivo predict the onset of heart failure and contractile dysfunction in rats with pressure overload.
    Doenst T; Pytel G; Schrepper A; Amorim P; Färber G; Shingu Y; Mohr FW; Schwarzer M
    Cardiovasc Res; 2010 Jun; 86(3):461-70. PubMed ID: 20035032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex Energy Metabolic Changes in Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction.
    De Jong KA; Lopaschuk GD
    Can J Cardiol; 2017 Jul; 33(7):860-871. PubMed ID: 28579160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction.
    Güven B; Sun Q; Wagg CS; Almeida de Oliveira A; Silver H; Persad KL; Onay-Besikci A; Vu J; Oudit GY; Lopaschuk GD
    J Pharmacol Exp Ther; 2024 Jan; 388(1):145-155. PubMed ID: 37977817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency.
    Ho KL; Zhang L; Wagg C; Al Batran R; Gopal K; Levasseur J; Leone T; Dyck JRB; Ussher JR; Muoio DM; Kelly DP; Lopaschuk GD
    Cardiovasc Res; 2019 Sep; 115(11):1606-1616. PubMed ID: 30778524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: evidence from fatty acid-binding protein-4 and -5 knockout mice.
    Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Yamaguchi A; Hanaoka H; Hishiki T; Nagahata-Naito Y; Obinata H; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
    Cardiovasc Res; 2018 Jul; 114(8):1132-1144. PubMed ID: 29554241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed Repolarization Underlies Ventricular Arrhythmias in Rats With Heart Failure and Preserved Ejection Fraction.
    Cho JH; Zhang R; Kilfoil PJ; Gallet R; de Couto G; Bresee C; Goldhaber JI; Marbán E; Cingolani E
    Circulation; 2017 Nov; 136(21):2037-2050. PubMed ID: 28974519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac Energy Metabolism in Heart Failure.
    Lopaschuk GD; Karwi QG; Tian R; Wende AR; Abel ED
    Circ Res; 2021 May; 128(10):1487-1513. PubMed ID: 33983836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism.
    Collins-Nakai RL; Noseworthy D; Lopaschuk GD
    Am J Physiol; 1994 Nov; 267(5 Pt 2):H1862-71. PubMed ID: 7977816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragaloside IV alleviates heart failure via activating PPARα to switch glycolysis to fatty acid β-oxidation.
    Dong Z; Zhao P; Xu M; Zhang C; Guo W; Chen H; Tian J; Wei H; Lu R; Cao T
    Sci Rep; 2017 Jun; 7(1):2691. PubMed ID: 28578382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Morphometric, Hemodynamic, and Multi-Omics Analyses in Heart Failure Rats with Preserved Ejection Fraction.
    Zhang W; Zhang H; Yao W; Li L; Niu P; Huo Y; Tan W
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ventricular Arrhythmias Underlie Sudden Death in Rats With Heart Failure and Preserved Ejection Fraction.
    Cho JH; Zhang R; Aynaszyan S; Holm K; Goldhaber JI; Marbán E; Cingolani E
    Circ Arrhythm Electrophysiol; 2018 Aug; 11(8):e006452. PubMed ID: 30030266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart.
    Jaswal JS; Keung W; Wang W; Ussher JR; Lopaschuk GD
    Biochim Biophys Acta; 2011 Jul; 1813(7):1333-50. PubMed ID: 21256164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of oxidative metabolism in volume-overloaded rat hearts: effect of propionyl-L-carnitine.
    El Alaoui-Talibi Z; Guendouz A; Moravec M; Moravec J
    Am J Physiol; 1997 Apr; 272(4 Pt 2):H1615-24. PubMed ID: 9139943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts.
    Allard MF; Schönekess BO; Henning SL; English DR; Lopaschuk GD
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H742-50. PubMed ID: 8067430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets.
    Fukushima A; Milner K; Gupta A; Lopaschuk GD
    Curr Pharm Des; 2015; 21(25):3654-64. PubMed ID: 26166604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of myocardial fatty acid oxidation prevents diastolic dysfunction in mice subjected to angiotensin II infusion.
    Choi YS; de Mattos AB; Shao D; Li T; Nabben M; Kim M; Wang W; Tian R; Kolwicz SC
    J Mol Cell Cardiol; 2016 Nov; 100():64-71. PubMed ID: 27693463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.